Seeking Alpha
 

Bruker Corporation (BRKR)

- NASDAQ
  • May. 7, 2014, 4:42 PM
    • Bruker Corporation (BRKR): Q1 EPS of $0.11 beats by $0.02.
    • Revenue of $423.7M (+7.7% Y/Y) beats by $21.68M.
    • Shares +6.8% AH.
    • Press Release
    | Comment!
  • Nov. 1, 2013, 9:13 AM
    | 1 Comment
  • May. 2, 2013, 6:10 PM
    After-hours top gainers, as of 5:15 p.m.: PKT +23%. BCOR +12%. INVN +8%. FORM +7%. FLT +6%.
    After-hours top losers: ZAGG -26%. VCRA -26%. GUID -20%. ARNA -15%. BRKR -11%.
    | Comment!
  • Jul. 24, 2012, 2:26 PM
    Bruker Corp. (BRKR -13.9%) is among the day's biggest losers after issuing downside guidance for Q2, seeing EPS of $0.11-$0.13 vs. $0.21 analyst consensus and revenues of $420M vs. $434.6M consensus. BRKR says results are adversely impacted by a weaker euro, softening customer demand and an increase in spending.
    | Comment!
  • Apr. 2, 2012, 3:19 PM
    Bruker (BRKR +4.8%) acquires Belgium-based scientific instruments company SkyScan; terms are not disclosed, but the acquisition is expected to add ~$13M to Bruker's revenue and to be accretive to EPS by about $0.01 for remainder of FY12.
    | Comment!
  • Oct. 7, 2011, 2:52 PM
    Illumina's (ILMN -32.2%) warning is taking a heavy toll on many companies dependent on medical research spending (I, II). Some of the other names tanking in sympathy: PKI -7.8%. LMNX -7.3%. TMO -5.7%. BRKR -3.5%. WAT -8%. PACB -11.4%. Fluidgm (FLDM -7.8%) is also among the casualties in spite of reaffirming its 2011 outlook.
    | Comment!
  • Oct. 7, 2011, 8:02 AM
    Bruker (BRKR) falls 9% premarket after Illumina's (ILMN) Q3 earnings miss taints shares on the outlook for "sluggishness" in the U.S. academic market.
    | Comment!
Visit Seeking Alpha's
BRKR vs. ETF Alternatives
Company Description
Bruker Corp is designer and manufacturer of life science & materials research systems in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics industries.